Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. (ECLIPSES)

PHASE4CompletedINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

July 10, 2013

Primary Completion Date

January 30, 2017

Study Completion Date

January 30, 2017

Conditions
Anemia FerropenicRisk of Hemoconcentration (Iron Levels >130g/L)
Interventions
DRUG

40mg/day of iron

Ferrimanitol ovalbumin granulated. Powder for oral solution. The doses of 40 mg per day of elemental iron correspond to 300 mg ferrimanitol ovoalbumin

DRUG

20mg/day of iron

Ferrimanitol ovalbumin granulated Powder for oral solution. The doses of 20 mg per day of elemental iron correspond to 150 mg ferrimanitol ovoalbumin

DRUG

80mg/day of iron

Ferrimanitol ovalbumin granulated. Powder for oral solution The doses of 80 mg per day of elemental iron correspond to 600 mg ferrimanitol ovoalbumin.

Trial Locations (2)

Unknown

Atención a la Salud Sexual y Reproductiva (ASSIR)- REUS- Altebrat, Reus

Atención a la Salud Sexual y Reproductiva (ASSIR)- Tarragona Valls, Tarragona

All Listed Sponsors
collaborator

University Rovira i Virgili

OTHER

collaborator

Catalan Institute of Health

OTHER_GOV

collaborator

Hospital Universitari Joan XXIII de Tarragona.

OTHER

collaborator

Carlos III Health Institute

OTHER_GOV

lead

Victoria Arija Val

OTHER

NCT03196882 - Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. (ECLIPSES) | Biotech Hunter | Biotech Hunter